Download for Citation Managers
ORIGINAL ARTICLE
Phase 1 dose escalation study of rigosertib by 2-, 4-, or 8-hour infusion twice-weekly in patients with advanced cancer Advani S H, Achrekar S D, Doval D C, Raghunadharao D, Wilhelm F E, Acharya M
Year : 2014 | Volume: 51 | Issue Number: 1 | Page: 40-44
Click here to read this article
|
|
|